Showing 421 - 440 results of 26,623 for search '(( 50 ((ng decrease) OR (teer decrease)) ) OR ( 50 ((nn decrease) OR (a decrease)) ))', query time: 0.77s Refine Results
  1. 421
  2. 422

    Methylation-Associated Partial Down-Regulation of Mesothelin Causes Resistance to Anti-Mesothelin Immunotoxins in a Pancreatic Cancer Cell Line by Kevin Hollevoet (710450)

    Published 2015
    “…Mesothelin cDNA introduction in KLM-1-R led to 5-fold higher surface protein levels and significantly higher RG7887 uptake compared to KLM-1. As a result, the original sensitivity to RG7787 was fully restored (IC<sub>50</sub> = 4.49 ± 1.11 ng/ml). …”
  3. 423
  4. 424
  5. 425
  6. 426
  7. 427
  8. 428
  9. 429
  10. 430
  11. 431
  12. 432
  13. 433
  14. 434
  15. 435

    Effects of siRNA TMPRSS2-ERG on ERG protein expression and cell viability. by Giorgia Urbinati (554921)

    Published 2015
    “…<p>VCaP cells were transfected for 24h, 48h and 72h with 50 nM of siRNAs TMPRSS2-ERG III (1, 2, 3), siRNAs TMPRSS2-ERG IV (1, 2), siRNA against ERG wild type or siRNA Control. …”
  16. 436
  17. 437
  18. 438
  19. 439

    Antineoplastic Effects of siRNA against TMPRSS2-ERG Junction Oncogene in Prostate Cancer by Giorgia Urbinati (554921)

    Published 2015
    “…The siRNA against TMPRSS2-ERG fusion variant IV showed the highest anti-proliferative effects: Significantly decreased cell viability, increased cleaved caspase-3 and inhibited a cluster of anti-apoptotic proteins. …”
  20. 440

    Low concentrations of siRNA TMPRSS2-ERG III and IV impair TMPRSS2-ERG oncogene and oncoprotein levels but not cell viability. by Giorgia Urbinati (554921)

    Published 2015
    “…<p>VCaP cells were transfected for 72h from 2.5 nM to 50 nM with siRNA TMPRSS2-ERG III, siRNA TMPRSS2-ERG IV or siRNA Control. …”